<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS135455</article-id>
<article-id pub-id-type="doi">10.1101/2021.09.20.461025</article-id>
<article-id pub-id-type="archive">PPR397337</article-id>
<article-version article-version-type="publisher-id">2</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Analysis of the upper respiratory tract microbiota in mild and severe COVID-19 patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Babenko</surname>
<given-names>V.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bakhtyev</surname>
<given-names>R.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baklaushev</surname>
<given-names>V.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Balykova</surname>
<given-names>L.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bashkirov</surname>
<given-names>P.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bespyatykh</surname>
<given-names>J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blagonravova</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boldyreva</surname>
<given-names>D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fedorov</surname>
<given-names>D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gafurov</surname>
<given-names>I.</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gaifullina</surname>
<given-names>R.</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Galeeva</surname>
<given-names>J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Galova</surname>
<given-names>E.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gospodaryk</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ilina</surname>
<given-names>E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ivanov</surname>
<given-names>K.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kharlampieva</surname>
<given-names>D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khromova</surname>
<given-names>P.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Klimina</surname>
<given-names>K.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kolontarev</surname>
<given-names>K.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kolyshkina</surname>
<given-names>N.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koritsky</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuropatkin</surname>
<given-names>V.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lazarev</surname>
<given-names>V.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manolov</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manuvera</surname>
<given-names>V.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matyushkina</surname>
<given-names>D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morozov</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moskaleva</surname>
<given-names>E.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Musarova</surname>
<given-names>V.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ogarkov</surname>
<given-names>O.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Orlova</surname>
<given-names>E.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pavlenko</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Petrova</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pozhenko</surname>
<given-names>N.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pushkar</surname>
<given-names>D.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rumyantsev</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rumyantsev</surname>
<given-names>S.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rumyantsev</surname>
<given-names>V.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rychkova</surname>
<given-names>L.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Samoilov</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shirokova</surname>
<given-names>I.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sinkov</surname>
<given-names>V.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Solovieva</surname>
<given-names>S.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Starikova</surname>
<given-names>E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tikhonova</surname>
<given-names>P.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Trifonova</surname>
<given-names>G.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Troitsky</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tulichev</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Udalov</surname>
<given-names>Y.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Varizhuk</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vasiliev</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vereshchagin</surname>
<given-names>R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Veselovsky</surname>
<given-names>V.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Volnukhin</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yusubalieva</surname>
<given-names>G.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Govorun</surname>
<given-names>V.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia</aff>
<aff id="A2">
<label>2</label>Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Moscow, Russia</aff>
<aff id="A3">
<label>3</label>City Clinical Hospital named after S.I. Spasokukotsky, Moscow, Russia</aff>
<aff id="A4">
<label>4</label>Burnasyan Federal Medical Biophysical Center, Moscow, Russia</aff>
<aff id="A5">
<label>5</label>Hospital of the Russian Academy of Sciences, Troitsk, Russia</aff>
<aff id="A6">
<label>6</label>Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk, Russia</aff>
<aff id="A7">
<label>7</label>Privolzhsky Research Medical University, Nizhny Novgorod, Russia</aff>
<aff id="A8">
<label>8</label>Kazan Federal University, Kazan, Russia</aff>
<aff id="A9">
<label>9</label>Russian Academy of Sciences, Russia</aff>
<pub-date pub-type="nihms-submitted">
<day>22</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="preprint">
<day>20</day>
<month>09</month>
<year>2021</year>
</pub-date>
<permissions>
<ali:free_to_read/>
<license>
<ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">The microbiota of the respiratory tract remains a relatively poorly studied subject. At the same time, like the intestinal microbiota, it is involved in modulating the immune response to infectious agents in the host organism. A causal relationship between the composition of the respiratory microbiota and the likelihood of development and the severity of COVID-19 may be hypothesized. We analyze biomaterial from nasopharyngeal smears from 336 patients with a confirmed diagnosis of COVID-19, selected during the first and second waves of the epidemic in Russia. Sequences from a similar study conducted in Spain were also included in the analysis. We investigated associations between disease severity and microbiota at the level of microbial community (community types) and individual microbes (differentially represented species). To search for associations, we performed multivariate analysis, taking into account comorbidities, type of community and lineage of the virus. We found that two out of six community types are associated with a more severe course of the disease, and one of the community types is characterized by high stability (very similar microbiota profiles in different patients) and low level of lung damage. Differential abundance analysis with respect to comorbidities and community type suggested association of <italic>Rothia</italic> and <italic>Streptococcus</italic> genera representatives with more severe lung damage, and <italic>Leptotrichia</italic>, unclassified Lachnospiraceae and <italic>Prevotella</italic> with milder forms of the disease.</p>
</abstract>
<kwd-group>
<kwd>COVID-19</kwd>
<kwd>SARS-CoV-2</kwd>
<kwd>respiratory microbiota</kwd>
<kwd>nasopharengeal swabs</kwd>
<kwd>metagenomic analysis</kwd>
<kwd>community types</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p id="P2">Commensal microorganisms of the respiratory tract affect the body’s ability to withstand the threat of viral infections [<xref ref-type="bibr" rid="R1">1</xref>] [<xref ref-type="bibr" rid="R2">2</xref>]. This effect is due to the modulatory influence of microbes on the immune system [<xref ref-type="bibr" rid="R3">3</xref>] or direct interaction between microbial metabolites with the viral life cycle [<xref ref-type="bibr" rid="R4">4</xref>].</p>
<p id="P3">At the same time, certain bacteria can promote viral infections [<xref ref-type="bibr" rid="R5">5</xref>] and bacterial secondary infections are leading to serious complications and mortalities during viral infections including new coronavirus disease [<xref ref-type="bibr" rid="R6">6</xref>][<xref ref-type="bibr" rid="R7">7</xref>][<xref ref-type="bibr" rid="R8">8</xref>]. Viral infections in turn can influence the bacterial community, sometimes promoting bacterial biofilm formation and secondary infections [<xref ref-type="bibr" rid="R9">9</xref>][<xref ref-type="bibr" rid="R10">10</xref>]. The close relationship between respiratory microbiota and viral infections renders it an important subject of study [<xref ref-type="bibr" rid="R11">11</xref>].</p>
<p id="P4">Until recently the microbiota of the upper respiratory tract was poorly studied, especially in adults [<xref ref-type="bibr" rid="R12">12</xref>]. This situation is changing in the context of the current coronavirus pandemic. Previous studies identified the existence and dynamical nature of microbial community types of upper respiratory tract during COVID-19 infection [<xref ref-type="bibr" rid="R13">13</xref>]. A number of studies described the differences between patients with COVID-19 and healthy people or differences among patients with different disease severity ([<xref ref-type="bibr" rid="R14">14</xref>][<xref ref-type="bibr" rid="R15">15</xref>] among others), see [<xref ref-type="bibr" rid="R16">16</xref>] for a short review. The results of different studies are quite different to each other which may be the result of phenotypic differences among groups studied (e.g. comorbidities), season and geographical factors and different techniques used in the data sampling and analysis.</p>
<p id="P5">Different approaches to study microbiota associations are used by different authors when analysing current COVID-19 pandemic samples. In [<xref ref-type="bibr" rid="R13">13</xref>] authors analyze throat and fecal specimens from 35 COVID-19 patients, 19 healthy adults and 10 non-COVID-19 patients. They obtained amplicon sequence variants (ASV) using DADA2 method, utilized Dirichlet multinomial mixtures probabilistic modelling and infer six community types, found associations between infection status and community type and also examined the change of type in the course of coronavirus disease. The majority of COVID-19 patients had microbial respiratory community type 2, characterized by higher abundance of <italic>Porphyromonas</italic>, <italic>Neisseria</italic>, <italic>Fusobacterium</italic> and Bacteriodales. The synchronous change of community types in the upper respiratory tract and gut was observed in a number of patients. In [<xref ref-type="bibr" rid="R14">14</xref>] authors examined 38 COVID-19 patients and 21 uninfected controls. They obtained amplicon sequence variants using DADA2 method, and utilized DESeq2 to infer ASVs associated with the COVID-19 and also with higher viral load. It was observed that <italic>Peptoniphilus lacrimalis</italic>, <italic>Campylobacter hominis</italic>, <italic>Prevotella copri</italic>, and an <italic>Anaerococcus</italic> unclassified amplicon sequence variant were associated with the disease and higher viral load, whereas <italic>Corynebacterium</italic> unclassified, textit-Staphylococcus haemolyticus, <italic>Prevotella disiens,</italic> and two <italic>Corynebacterium_1</italic> unclassified amplicon sequence variants were associated with healthy status and low viral load during COVID-19.</p>
<p id="P6">Respiratory microbiome has geographic and climatic characteristics, so it is important to study its relationship with COVID-19 in many regions. It is also essential to take into account other diseases and habits of patients when analyzing the associations between the composition of the microbiota and the severity of the course of covid disease, to lower the rate of spurious correlations.</p>
<p id="P7">In our work, we describe the composition of the respiratory microbiome in 219 inpatients and 146 outpatients with COVID-19. We performed SARS-CoV-2 genome sequencing and metagenomic analysis of nasopharyngeal swabs to find associations with the disease severity. As far as we know, the current paper is the first description of the respiratory tract of patients with COVID from Russia and one of the few studies in which microbiome analysis was performed regarding patient’s comorbidities.</p>
<p id="P8">Two approaches were used in metagenomic data analysis. First we inferred groups of microbial communities using Dirichlet multinomial mixtures (DMM) probabilistic modelling. Groups of microbial communities unite communities with similar taxonomic profiles, and modeling of taxonomic profiles as the result of multinomial sampling addresses the compositional nature of metagenomic sequencing data [<xref ref-type="bibr" rid="R17">17</xref>]. This method gained popularity in microbiome research in recent years [<xref ref-type="bibr" rid="R18">18</xref>][<xref ref-type="bibr" rid="R19">19</xref>][<xref ref-type="bibr" rid="R13">13</xref>].</p>
<p id="P9">Secondly we aimed at identification of microorganisms associated with more severe forms of disease using differential abundance testing with the use of patient’s metainformation as covariates. Microbial community type was also used as covariate to separate the effects on the community level as a whole and the influence of individual microorganisms. We performed testing with the DESeq2 [<xref ref-type="bibr" rid="R20">20</xref>] method which demonstrates sensitivity and low false positive rate in the microbiome data analysis [<xref ref-type="bibr" rid="R21">21</xref>].</p>
<p id="P10">We found that two out of six community types are associated with a more severe course of the disease, and one of the community types is characterized by high microbial content stability and low level of lung damage in patients. Differential abundance analysis suggested association of <italic>Rothia</italic> and <italic>Streptococcus</italic> genera representatives with more severe lung damage, and <italic>Leptotrichia</italic>, unclassified Lachnospiraceae and <italic>Prevotella</italic> with milder forms of the disease. The wide geographical and age coverage of COVID-19 patients with taking into account their comorbidities allows us to hope for further reproducibility of the obtained results.</p>
</sec>
<sec id="S2" sec-type="results">
<title>Results</title>
<sec id="S3">
<label>2.1</label>
<title>Study cohort</title>
<p id="P11">336 patients were enrolled in the study aged up to 94 years, 203 females and 131 males, 140 outpatients and 196 inpatients (the total number of patients and the number of patients in the groups will not match due to some missing data). Samples were collected between 2020-05 and 2021-03 (collection dates capture the decay of wave 1 and the entire period of wave 2 of covid 19 incidence) in the following cities of Russian Federation: Moscow, Kazan, Irkutsk, Nizhny Novgorod (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<p id="P12">Data on both inpatients and outpatients were obtained for the city of Irkutsk. For the city of Kazan, we had only outpatients and data on them was used only when analyzing community types. The following clinical information was collected: computer tomography severity score (CT), percent of lung tissue affected, temperature, oxygen saturation level, respiratory rate, heart rate, systolic and diastolic blood pressure, being conscious and the need for additional oxygen supply. The following metadata was collected based on questionnaires: presence of obesity, diabetes, chronic obstructive pulmonary disease (COPD), inflammatory bowel disease (IBD), arthritis, tuberculosis, hypertension, coronary artery disease, chronic heart failure, asthma, current and past smoking status.</p>
</sec>
<sec id="S4">
<label>2.2</label>
<title>Analysis of comorbidities and habits associated with the disease severity</title>
<p id="P13">We analyzed the association of various available clinical and non-clinical parameters with the proportion of affected lung tissue. The presence of hyper-tension was significantly associated with linear model analysis (p-value &lt; 0.001) which is in agreement with previous reports [<xref ref-type="bibr" rid="R22">22</xref>]. No other associations of disease severity and patient data and comorbidities were found, presumably due to the relatively small number of patients. No associations of disease severity and virus genome lineage (pangolin classification) were found to be statistically significant.</p>
</sec>
<sec id="S5">
<label>2.3</label>
<title>SARS-CoV-2 genome sequences</title>
<p id="P14">We sequenced genomes of SARS-CoV-2 virus amplified from the patient’s swabs. The coverage width of the 258 genome sequences was higher than 90</p>
<p id="P15">Most of the genomes belonged to B.* pangolin lineages, namely: B.1.1 (183 sequences, found all over the world), B.1.1.317 (26 sequences, prevalent in Russia and other European countries), B.1 (16 sequences, found all over the world), B.1.1.294 (12 sequences, prevalent in Russia and other European countries), B.1.1.163 (7 sequences, sampled mainly in Russia); one genome belonged to M3 lineage, which is mainly sampled in England.</p>
<p id="P16">We observed significant association between lineages and the city of sample collection (Fisher test with simulated p-values, p-value &lt; 3 × 10<sup>−5</sup>). Uneven prevalence was observed mostly for lineage B.1.1.294 which was quite frequently observed in Kazan (exact Fisher test, p-value &lt; 0.002).</p>
<p id="P17">No association was found between pangolin lineage of the virus genome and CT score or percentage of lung damage (linear models analys).</p>
</sec>
<sec id="S6">
<label>2.4</label>
<title>Respiratory microbiome analysis</title>
<p id="P18">The 16S-rRNA gene sequences were resolved into 3341 amplicon sequence variants (ASVs) representing 345 genera. Further we will describe the analysis of community types, analysis of factors associated with community types and the association of community types with clinical indicators and will conclude with differential abundance analysis on the genus and ASV levels.</p>
<sec id="S7">
<label>2.4.1</label>
<title>Microbial community types analysis</title>
<p id="P19">Microbial community types analysis We observed the presence of several clusters of taxonomic profiles in our data (see <xref ref-type="fig" rid="F2">Figure 2</xref>). We analyzed jointly our data and data from work [<xref ref-type="bibr" rid="R23">23</xref>] to infer community types using Dirichlet multi-nomial mixtures (DMM) modelling. A joint analysis was performed to increase confidence in the resulting clusters. We got 6 community types based on the Laplace approximation criteria (<xref ref-type="fig" rid="F2">Figure 2 A,C</xref>).</p>
<p id="P20">
<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 2</xref> shows estimated relative abundances of different microbial genus in six community types.</p>
<p id="P21">According to our analysis, the main drivers of community types 1 and 4 are <italic>Streptococcus</italic>, <italic>Prevotella</italic> and <italic>Veillonella</italic> genera, but community type 4 is characterized by larger alpha diversity (<xref ref-type="fig" rid="F4">Figure 4 C</xref>). Community type 2 is similar to them and has the same top three drivers, but <italic>Prevotella</italic> prevails over streptococci. Community types 3 and 5 are also similar to each other with the most represented genera being <italic>Staphylococcus</italic>, <italic>Pseudomonas</italic> and <italic>Corynebacterium</italic> for type 3 and <italic>Staphylococcus</italic>, <italic>Pseudomonas</italic>, <italic>Streptococcus</italic> for type 5. Community type 6 is mainly dominated by <italic>Pseudomonas</italic> and <italic>Stentotraphomonas</italic> genera. The communities are numbered in descending order of the number of samples assigned to them.</p>
</sec>
<sec id="S8">
<label>2.4.2</label>
<title>Factors affecting the type of community</title>
<p id="P22">We analyzed the association between the variables characterizing the patient and his or her condition and the microbial community type using the following approaches. First, we ran the Kruskal-Wallis nonparametric statistical test for each of the numerical variables (<xref ref-type="fig" rid="F3">Figure 3 A</xref>) and the chi-squared test for each of the categorical variables (<xref ref-type="fig" rid="F3">Figure 3 B</xref>). We also applied the random forest method to estimate the importance of both categorical and numerical variables (<xref ref-type="fig" rid="F3">Figure 3 C</xref>).</p>
<p id="P23">Different methods give different results but their consensus is that city and month of sample collection and patient’s age are the most significant variables associated with the microbial community type. The association between age and the composition of the upper respiratory tract microbial community is rather well known [<xref ref-type="bibr" rid="R24">24</xref>]. The influence of season of sample collection on microbiota composition was previously shown for children [<xref ref-type="bibr" rid="R25">25</xref>]. Air microbiome was shown to be season and geographical location dependent in [<xref ref-type="bibr" rid="R26">26</xref>] with Pseudomonas genera being one of the most variable community members (see <xref ref-type="fig" rid="F3">Figure 3</xref> from [<xref ref-type="bibr" rid="R26">26</xref>]).</p>
<p id="P24">As shown by post hoc analysis, community types 2 and 4 are associated with an earlier age of the patients (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1 A</xref>, statistical analysis performed with dune’s test) with community types 2 and 4 containing younger people than other types. The strongest association with the month of sample collection is observed in community type 3 (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1 B</xref>), samples belonging to this type were collected mainly in winter.</p>
<p id="P25">Different cities have different distributions of community types (Fisher exact test with simulated p-values for all possible pairs of cities, FDR adjusted p-value &lt; 0.05), with the only exception being the comparison of Moscow and Novgorod, the difference between which is not significant. As shown in <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1C</xref> in Moscow and Nizhniy Novgorod predominates community type 1; in Kazan city type 3 is more prevalent and in Irkutsk city a relatively uniform distribution of types 1, 2 and 4 is observed. Samples from [<xref ref-type="bibr" rid="R23">23</xref>] which were collected in Alicante belonged mainly to community types 2 and 1.</p>
</sec>
<sec id="S9">
<label>2.4.3</label>
<title>Association of microbial community types with disease severity</title>
<p id="P26">We observed a statistically significant difference in the need of additional oxygen supply for patients with microbiota of different types (p-value &lt; 0.003, Fisher exact test). There were some differences in the degree of lung damage, but it was not statistically significant (Kruskall-Wallis test, p-values ¿ 0.05). As a trend, we observe a larger lung damage and larger need in O2 supply in community type 5, which also shows the lowest alpha-diversity (<xref ref-type="fig" rid="F4">Figure 4 A, B, C</xref>).</p>
<p id="P27">As well, the high proportion of patients with additional oxygen needs has type 2 microbial community. Interesting that the majority of patients with a severe form of the COVID-19 from the [<xref ref-type="bibr" rid="R23">23</xref>] study also belonged to the second type of community.</p>
<p id="P28">A comparison of in- and outpatients from the city of Irkutsk (the only city where we managed to collect samples of both types) showed that the microbiota of inpatients belongs mainly to community types 1 and 2, and the microbiota of outpatients belongs mainly to type 4. The type 4 community had the highest level of alpha diversity and patients with this type of community rarely required additional oxygen supply while having sufficiently high levels of lung damage.</p>
<p id="P29">As was mentioned above, in our study the 5th type of community having the extremely low level of alpha diversity was predominant in patients with a high percentage of lung damage and often needed oxygen supply. Otherwise in [<xref ref-type="bibr" rid="R23">23</xref>] this type was found mainly in patients belonged to group A: SARS-CoV-2 negative patients (n = 18) and group B: mild COVID-19 symptoms but no later hospital admission (n = 19) (<xref ref-type="fig" rid="F4">Figure 4D</xref>).</p>
<p id="P30">The 6th type of community was the most stable in its composition (<xref ref-type="fig" rid="F2">figure 2 A</xref>). Patients having this type of community were sampled in different cities, had no need for additional oxygen supply, and had a low level of lung damage.</p>
</sec>
<sec id="S10">
<label>2.4.4</label>
<title>Microbial associations of disease severity with respect to community type, season and comorbidities</title>
<p id="P31">To search for the potential effect of microbiome composition on the severity of COVID-19, we took into account the following metadata: age, sex of the patient, presence of hypertension, city and season of the sampling, microbial community type and the SARS-CoV-2 virus lineage. We analyzed the differentially abundant genus, between patients with mild (CT 1) and more severe (CT 2 - 4) levels of lung damage, using the DESeq2 method [<xref ref-type="bibr" rid="R20">20</xref>].</p>
<p id="P32">It may be noted that in patients with mild lung damage (CT 1), significantly (p-value &lt; 0.01) predominates bacteria belonging to Fusobacteria phylum which are known as commensals of the upper respiratory and gastrointestinal tracts in humans and animals. In particular, based on analysis on the level of amplicon sequence variants (ASV) we observed the overrepresentation of bacteria from the <italic>Leptotrichia</italic> genus, especially ASV34 and ASV155, which have identical sequences with <italic>Leptotrichia wadei</italic> and a number of uncultured bacteria, respectively.</p>
<p id="P33">
<italic>Leptotrichia</italic> species are anaerobic or facultative anaerobic species frequently found in the oral cavity and are able to produce lactic and some other organic acids [<xref ref-type="bibr" rid="R27">27</xref>]. We are unaware of the possible positive biological role of <italic>L. wadei</italic> and uncultured <italic>Leptotrichia</italic> species in promoting milder disease. It can also be assumed that the upper respiratory tract microbiota characteristic for healthy people remain in the group of patients with mild lung damage.</p>
<p id="P34">The <italic>Prevotella</italic> genera and unclassified Lachnospiraceae (both on the genus and ASV levels) also appeared to be associated with mild lung damage. Along with <italic>Leptotrichia</italic>, <italic>Prevotella</italic> species belonging to Bacteroidetes phylum are mainly known as commensals in the respiratory tract and rarely cause respiratory infections [<xref ref-type="bibr" rid="R28">28</xref>]. Depletion of <italic>Prevotella</italic> was observed in patients with influenza infection [<xref ref-type="bibr" rid="R29">29</xref>][<xref ref-type="bibr" rid="R30">30</xref>] and also in a group of patients with different acute viral infections (influenza A, influenza B, rhinovirus, metapneumovirus and respiratory syncytial virus) [<xref ref-type="bibr" rid="R31">31</xref>]. But <italic>Prevotella</italic> spp. produced proteins were found to be abundant in the lung metagenomic studies of SARS-CoV-2 infected patients [<xref ref-type="bibr" rid="R32">32</xref>].</p>
<p id="P35">The Lachnospiraceae family is a phylogenetically and morphologically heterogeneous taxon belonging to the Firmicutes phylum. It is considered to be a member of the core gut microbiota, but also found in bronchoalveolar lavage and sputum. Bacteria from the Lachnospiraceae family are able to ferment sugars and produce butyrate and other short-chain fatty acids (SCFAs) in the gut [<xref ref-type="bibr" rid="R33">33</xref>]. SCFAs are known to facilitate gut barrier function and to modulate the immune system with mostly beneficial effects [<xref ref-type="bibr" rid="R34">34</xref>], including protection against respiratory viruses [<xref ref-type="bibr" rid="R35">35</xref>]. These substances also play a role in a gut-brain axis [<xref ref-type="bibr" rid="R36">36</xref>]. The role of SCFAs in the respiratory tract is less studied, while they can be found in bronchoalveolar lavages [<xref ref-type="bibr" rid="R37">37</xref>] and potentially can affect airway inflammatory responses [<xref ref-type="bibr" rid="R38">38</xref>][<xref ref-type="bibr" rid="R39">39</xref>]. Previously, it was shown that the presence of the Lachnospiraceae in bronchoalveolar lavage samples predicted worse ICU outcomes for critically ill patients [<xref ref-type="bibr" rid="R40">40</xref>]. According to our data it seems that Lachnospiraceae somehow protect the people with COVID-19 from developing the severe lung damage, but it should be analyzed in more detail in the future studies.</p>
<p id="P36">Among the patients with severe lung damage (CT2-4) we observed the overrepresentation of bacteria from <italic>Rothia</italic> (p-value &lt; 0.01) and <italic>Solobacterium</italic> (p-value &lt; 0.05) genera. <italic>Rothia</italic> species (<italic>R. mucilaginosa</italic>, <italic>R. dentocariosa</italic>, <italic>R. aeria</italic>, <italic>R. nasimurium</italic>, and <italic>R. amarae</italic>) being a part of the normal flora of the human oropharynx and upper respiratory tract, can cause a wide range of serious infections, including pneumoniae, especially in immunocompromised people. Earlier bacteria from the <italic>Rothia</italic> genus have been already observed in association with COVID-19. In [<xref ref-type="bibr" rid="R13">13</xref>] this genus was described as a major taxon in one of the throat microbial community types represented in patients but not in healthy controls. In another study, ASV identical to 16S rRNA of <italic>Rothia dentocariosa</italic> was found to be overrepresented in samples from COVID-19 patients [<xref ref-type="bibr" rid="R41">41</xref>]. There is also at least one published work describing the lower abundance of <italic>Rothia</italic> species in COVID-19 patients [<xref ref-type="bibr" rid="R42">42</xref>]. The analysis performed on the ASV level showed that three ASVs from the <italic>Streptococcus</italic> genus and one ASV of the <italic>Anaerococcus</italic> genus are overrepresented in patients with more severe lung damage.</p>
<p id="P37">Three Streptococci ASVs associated with greater lung damage have exact sequence match with <italic>Streptococcus mitis/oralis</italic> (ASV1), <italic>Streptococcus parasanguinis</italic> (ASV5) and <italic>Streptococcus anginosus</italic> (ASV153) 16S rRNA sequences. These species are representatives of viridans group streptococci having mainly commensal relationships with the human host, but also capable of causing or promoting respiratory infections [<xref ref-type="bibr" rid="R43">43</xref>]. <italic>Oral/mitis</italic> streptococci were previously described as potentially contributing to influenza viral infection [<xref ref-type="bibr" rid="R4">4</xref>], supernatants of these bacteria promoted viral release and spread presumably due to neuraminidase production by these bacteria. <italic>Streptococcus anginosus</italic> plays an important role in respiratory infections [<xref ref-type="bibr" rid="R44">44</xref>], including bacterial pneumonia in COVID-19 patients [<xref ref-type="bibr" rid="R45">45</xref>]. The abundance of <italic>Streptococcus</italic> genera and particularly of <italic>S. parasanguinis</italic> on hospital admission, was identified as a strong predictor of fatality in COVID-19 patients [?].</p>
</sec>
</sec>
</sec>
<sec id="S11">
<label>3</label>
<title>Summary</title>
<p id="P38">Our study aimed at characterization of nasopharyngeal microbiota characterization of COVID-19 patients with different levels of disease severity.</p>
<p id="P39">First, we performed analysis on the level of community types. Mixture model analysis resulted in six types of bacterial communities. Among the factors associated with community type are geographic location and month of sample collection and the age of the patient. As a trend, patients with community type dominated by <italic>Pseudomonas</italic> and <italic>Stentotraphomonas</italic> genera had relatively low lung damage and no need for additional O2 supply. Patients with low alpha-diversity community type with <italic>Staphylococcus</italic>, <italic>Pseudomonas</italic>, <italic>Streptococcus</italic> as top genera demonstrated the highest lung damage.</p>
<p id="P40">Next we performed the analysis of differentially abundant taxonomic units with respect to confounding parameters, including respiratory community type, inferred <italic>Rothia</italic> and <italic>Solobacterium</italic> genera and sequence variant of <italic>Streptococcus mitis/oralis</italic> group to be positively correlated with larger lung damage levels. <italic>Leptotrichia</italic> and unclassified Lachnospiraceae genera, sequence variants belonging to Prevotella genus were observed to be associated with lower lung damage.</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary figure 1. Distribution of the patient's age and the month of sampling between</label>
<media xlink:href="EMS135455-supplement-Supplementary_figure_1__Distribution_of_the_patient_s_age_and_the_month_of_sampling_between.jpg" mimetype="image" mime-subtype="jpeg" id="N67048" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>Supplementary figure 2. Estimated relative abundance of different microbial genus in six community</label>
<media xlink:href="EMS135455-supplement-Supplementary_figure_2__Estimated_relative_abundance_of_different_microbial_genus_in_six_community.pdf" mimetype="application" mime-subtype="pdf" id="N67057" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S12">
<title>Acknowledgments</title>
<p>We thank the Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency for providing computational resources for this project.</p>
<sec id="S13">
<title>Funding</title>
<p>This study was funded by Russian Science Foundation (21-15-00431).</p>
</sec>
</ack>
<fn-group>
<fn id="FN1">
<p id="P41">
<bold>Ethics approval and consent to participate.</bold> The study was approved by the ethical committee of RCPCM. All patients gave written informed consent for sample collection and personal data processing.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>[1]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abt</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Osborne</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Monticelli</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Doering</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Alenghat</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sonnenberg</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Paley</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Antenus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Erikson</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Commensal bacteria calibrate the activation threshold of innate antiviral immunity</article-title>
<source>Immunity</source>
<year>2012</year>
<volume>37</volume>
<issue>1</issue>
<fpage>158</fpage>
<lpage>170</lpage>
</element-citation>
</ref>
<ref id="R2">
<label>[2]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shedden</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kuan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Balmaseda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Foxman</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The respiratory microbiome and susceptibility to influenza virus infection</article-title>
<source>PLOS ONE</source>
<year>2019</year>
<volume>14</volume>
<issue>1</issue>
<elocation-id>0207898</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0207898</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>[3]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abt</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Osborne</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Monticelli</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Doering</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Alenghat</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sonnenberg</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Paley</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Antenus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Erikson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wherry</surname>
<given-names>EJ</given-names>
</name>
<etal/>
</person-group>
<article-title>Commensal bacteria calibrate the activation threshold of innate antiviral immunity</article-title>
<source>Immunity</source>
<year>2012</year>
<volume>37</volume>
<issue>1</issue>
<fpage>158</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2012.04.011</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>[4]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamio</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Imai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cueno</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Tamura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ochiai</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Neuraminidase-producing oral mitis group streptococci potentially contribute to influenza viral infection and reduction in antiviral efficacy of zanamivir</article-title>
<source>Cellular and Molecular Life Sciences</source>
<year>2014</year>
<volume>72</volume>
<issue>2</issue>
<fpage>357</fpage>
<lpage>366</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-014-1669-1</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>[5]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellinghausen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gulraiz</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Heinzmann</surname>
<given-names>ACA</given-names>
</name>
<name>
<surname>Dentener</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Savelkoul</surname>
<given-names>PHM</given-names>
</name>
<name>
<surname>Wouters</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Rohde</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Stassen</surname>
<given-names>FR</given-names>
</name>
</person-group>
<article-title>Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection</article-title>
<source>Respiratory Research</source>
<year>2016</year>
<volume>17</volume>
<issue>1</issue>
<pub-id pub-id-type="doi">10.1186/s12931-016-0382-z</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>[6]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morens</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Taubenberger</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Fauci</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness</article-title>
<source>The Journal of Infectious Diseases</source>
<year>2008</year>
<volume>198</volume>
<issue>7</issue>
<fpage>962</fpage>
<lpage>970</lpage>
<pub-id pub-id-type="doi">10.1086/591708</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>[7]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lansbury</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Baskaran</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>WS</given-names>
</name>
</person-group>
<article-title>Co-infections in people with COVID-19: a systematic review and meta-analysis</article-title>
<source>Journal of Infection</source>
<year>2020</year>
<volume>81</volume>
<issue>2</issue>
<fpage>266</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinf.2020.05.046</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>[8]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, china: a descriptive study</article-title>
<source>The Lancet</source>
<year>2020</year>
<volume>395</volume>
<issue>10223</issue>
<fpage>507</fpage>
<lpage>513</lpage>
<pub-id pub-id-type="doi">10.1016/s0140-6736(20)30211-7</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>[9]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hendricks</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Lashua</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Flitter</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Eichinger</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Coyne</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Empey</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Bomberger</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Respiratory syncytial virus infection enhancesPseudomonas aeruginosabiofilm growth through dysregulation of nutritional immunity</article-title>
<source>Proceedings of the National Academy of Sciences</source>
<year>2016</year>
<volume>113</volume>
<issue>6</issue>
<fpage>1642</fpage>
<lpage>1647</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1516979113</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>[10]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hendricks</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Melvin</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Stolz</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Sadovsky</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bomberger</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Extracellular vesicles promote transkingdom nutrient transfer during viral-bacterial co-infection</article-title>
<source>Cell Reports</source>
<year>2021</year>
<volume>34</volume>
<issue>4</issue>
<elocation-id>108672</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.celrep.2020.108672</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>[11]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Man</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>de Steenhuijsen Piters</surname>
<given-names>WAA</given-names>
</name>
<name>
<surname>Bogaert</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The microbiota of the respiratory tract: gatekeeper to respiratory health</article-title>
<source>Nature Reviews Microbiology</source>
<year>2017</year>
<volume>15</volume>
<issue>5</issue>
<fpage>259</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro.2017.14</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>[12]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubourg</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Edouard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Raoult</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Relationship between nasopharyngeal microbiota and patient’s susceptibility to viral infection</article-title>
<source>Expert Review of Anti-infective Therapy</source>
<year>2019</year>
<volume>17</volume>
<issue>6</issue>
<fpage>437</fpage>
<lpage>447</lpage>
<pub-id pub-id-type="doi">10.1080/14787210.2019.1621168</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>[13]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults</article-title>
<source>Communications Biology</source>
<year>2021</year>
<volume>4</volume>
<issue>1</issue>
<pub-id pub-id-type="doi">10.1038/s42003-021-01796-w</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>[14]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosas-Salazar</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Shilts</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Strickland</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Wessinger</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Rajagopala</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome</article-title>
<source>Journal of Allergy and Clinical Immunology</source>
<year>2021</year>
<volume>147</volume>
<issue>4</issue>
<fpage>1226</fpage>
<lpage>12332</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2021.02.001</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>[15]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soltani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zakeri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zandi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kesheh</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Tabibzadeh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Das-tranj</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Faramarzi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Didehdar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hafezi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hosseini</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Farahani</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The role of bacterial and fungal human respiratory microbiota in COVID-19 patients</article-title>
<source>BioMed Research International</source>
<year>2021</year>
<volume>2021</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1155/2021/6670798</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>[16]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tamura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Prawisuda</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mizutani</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yotsuyanagi</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The human microbiome and COVID-19: A systematic review</article-title>
<source>PLOS ONE</source>
<year>2021</year>
<volume>16</volume>
<issue>6</issue>
<elocation-id>0253293</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0253293</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>[17]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmes</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Quince</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Dirichlet multinomial mixtures: Generative models for microbial metagenomics</article-title>
<source>PLoS ONE</source>
<year>2012</year>
<volume>7</volume>
<issue>2</issue>
<elocation-id>30126</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0030126</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>[18]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Ajami</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Hutchinson</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Doddapaneni</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Metcalf</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Muzny</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Temporal development of the gut microbiome in early childhood from the TEDDY study</article-title>
<source>Nature</source>
<year>2018</year>
<volume>562</volume>
<issue>7728</issue>
<fpage>583</fpage>
<lpage>588</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-018-0617-x</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>[19]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Schloss</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>Dynamics and associations of microbial community types across the human body</article-title>
<source>Nature</source>
<year>2014</year>
<volume>509</volume>
<issue>7500</issue>
<fpage>357</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="doi">10.1038/nature13178</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>[20]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>
<source>Genome Biology</source>
<year>2014</year>
<volume>15</volume>
<issue>12</issue>
<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>[21]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrison</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Calder</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Shastry</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Buerkle</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Dirichlet-multinomial modelling outperforms alternatives for analysis of microbiome and other ecological count data</article-title>
<source>Molecular Ecology Resources</source>
<year>2020</year>
<volume>20</volume>
<issue>2</issue>
<fpage>481</fpage>
<lpage>497</lpage>
<pub-id pub-id-type="doi">10.1111/1755-0998.13128</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>[22]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zha</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis</article-title>
<source>Nutrition Metabolism and Cardiovascular Diseases</source>
<year>2021</year>
<volume>31</volume>
<issue>3</issue>
<fpage>745</fpage>
<lpage>755</lpage>
<pub-id pub-id-type="doi">10.1016/j.numecd.2020.12.009</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>[23]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ventero</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Cuadrat</surname>
<given-names>RRC</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>BGN</given-names>
</name>
<name>
<surname>Molina-Pardines</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Haro-Moreno</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Coutinho</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Merino</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Regit-ano</surname>
<given-names>LCA</given-names>
</name>
<name>
<surname>Silveira</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Afli</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Nasopharyngeal microbial communities of patients infected with SARS-CoV-2 that developed COVID-19</article-title>
<source>Frontiers in Microbiology</source>
<year>2021</year>
<volume>12</volume>
<pub-id pub-id-type="doi">10.3389/fmicb.2021.637430</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>[24]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yong</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>Y-J</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Profiling bacterial community in upper respiratory tracts</article-title>
<source>BMC Infectious Diseases</source>
<year>2014</year>
<volume>14</volume>
<issue>1</issue>
<pub-id pub-id-type="doi">10.1186/s12879-014-0583-3</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>[25]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bogaert</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Keijser</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Huse</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rossen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Veenhoven</surname>
<given-names>R</given-names>
</name>
<name>
<surname>van Gils</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bruin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Montijn</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bonten</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Variability and diversity of nasopharyngeal microbiota in children: A metagenomic analysis</article-title>
<source>PLoS ONE</source>
<year>2011</year>
<volume>6</volume>
<issue>2</issue>
<elocation-id>17035</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0017035</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>[26]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Núñez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>García</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Guantes</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Seasonal changes dominate long-term variability of the urban air microbiome across space and time</article-title>
<source>Environment International</source>
<year>2021</year>
<volume>150</volume>
<elocation-id>106423</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.envint.2021.106423</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>[27]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eribe</surname>
<given-names>ERK</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Leptotrichia species in human infections II</article-title>
<source>Journal of Oral Microbiology</source>
<year>2017</year>
<volume>9</volume>
<issue>1</issue>
<elocation-id>1368848</elocation-id>
<pub-id pub-id-type="doi">10.1080/20002297.2017.1368848</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>[28]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Steenhuijsen Piters</surname>
<given-names>WAA</given-names>
</name>
<name>
<surname>Huijskens</surname>
<given-names>EGW</given-names>
</name>
<name>
<surname>Wyllie</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Bies-broek</surname>
<given-names>G</given-names>
</name>
<name>
<surname>van den Bergh</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Veenhoven</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Trzciński</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bonten</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Rossen</surname>
<given-names>JWA</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>EAM</given-names>
</name>
<etal/>
</person-group>
<article-title>Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients</article-title>
<source>The ISME Journal</source>
<year>2015</year>
<volume>10</volume>
<issue>1</issue>
<fpage>97</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1038/ismej.2015.99</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>[29]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leung</surname>
<given-names>RK-K</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J-W</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S-K</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z-F</given-names>
</name>
<name>
<surname>Tsui</surname>
<given-names>SK-W</given-names>
</name>
</person-group>
<article-title>Modulation of potential respiratory pathogens by pH1n1 viral infection</article-title>
<source>Clinical Microbiology and Infection</source>
<year>2013</year>
<volume>19</volume>
<issue>10</issue>
<fpage>930</fpage>
<lpage>935</lpage>
<pub-id pub-id-type="doi">10.1111/1469-0691.12054</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>[30]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>16s rDNA sequencing analysis of upper respiratory tract flora in patients with influenza h1n1 virus infection</article-title>
<source>Frontiers in Laboratory Medicine</source>
<year>2017</year>
<volume>1</volume>
<issue>1</issue>
<fpage>16</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1016/j.flm.2017.02.005</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>[31]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edouard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Million</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bachar</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dubourg</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Michelle</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ninove</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Charrel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Raoult</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens</article-title>
<source>European Journal of Clinical Microbiology &amp; Infectious Diseases</source>
<year>2018</year>
<volume>37</volume>
<issue>9</issue>
<fpage>1725</fpage>
<lpage>1733</lpage>
<pub-id pub-id-type="doi">10.1007/s10096-018-3305-8</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>[32]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>COVID-2019-associated overexpressed prevotella proteins mediated host−pathogen interactions and their role in coronavirus outbreak</article-title>
<source>Bioinformatics</source>
<year>2020</year>
<volume>36</volume>
<issue>13</issue>
<fpage>4065</fpage>
<lpage>4069</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btaa285</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>[33]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vacca</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Celano</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Calabrese</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Portincasa</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gobbetti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Angelis</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>The controversial role of human gut lachnospiraceae</article-title>
<source>Microorganisms</source>
<year>2020</year>
<volume>8</volume>
<issue>4</issue>
<fpage>573</fpage>
<pub-id pub-id-type="doi">10.3390/microorganisms8040573</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>[34]</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McKenzie</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Potamitis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thorburn</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Macia</surname>
<given-names>L</given-names>
</name>
</person-group>
<chapter-title>The role of short-chain fatty acids in health and disease</chapter-title>
<source>Advances in Immunology</source>
<publisher-name>Elsevier</publisher-name>
<year>2014</year>
<fpage>91</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="doi">10.1016/b978-0-12-800100-4.00003-9</pub-id>
<comment>???</comment>
</element-citation>
</ref>
<ref id="R35">
<label>[35]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antunes</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Fachi</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>de Paula</surname>
<given-names>R</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Pral</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>dos Santos</surname>
<given-names>AÁ</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>GBM</given-names>
</name>
<name>
<surname>Vargas</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Puga</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>FQ</given-names>
</name>
<name>
<surname>Maito</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response</article-title>
<source>Nature Communications</source>
<year>2019</year>
<volume>10</volume>
<issue>1</issue>
<pub-id pub-id-type="doi">10.1038/s41467-019-11152-6</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>[36]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>YP</given-names>
</name>
<name>
<surname>Bernardi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Frozza</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>The role of short-chain fatty acids from gut microbiota in gut-brain communication</article-title>
<source>Frontiers in Endocrinology</source>
<year>2020</year>
<volume>11</volume>
<pub-id pub-id-type="doi">10.3389/fendo.2020.00025</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>[37]</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Koliana</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Kebadze</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Blanchard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Frost</surname>
<given-names>G</given-names>
</name>
</person-group>
<chapter-title>Presence of airway SCFAs in asthma and response of airway epithelium to SCFAs</chapter-title>
<source>Airway Cell Biology and Immunopathology</source>
<publisher-name>European Respiratory Society</publisher-name>
<year>2019</year>
<pub-id pub-id-type="doi">10.1183/13993003.congress-2019.pa2379</pub-id>
<comment>???</comment>
</element-citation>
</ref>
<ref id="R38">
<label>[38]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghorbani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Santhakumar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Djiadeu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wolever</surname>
<given-names>TMS</given-names>
</name>
<name>
<surname>Palaniyar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Grasemann</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth</article-title>
<source>European Respiratory Journal</source>
<year>2015</year>
<volume>46</volume>
<issue>4</issue>
<fpage>1033</fpage>
<lpage>1045</lpage>
<pub-id pub-id-type="doi">10.1183/09031936.00143614</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>[39]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>J-Y</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Sohn</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S-H</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>H-R</given-names>
</name>
</person-group>
<article-title>Effects of respiratory short-chain fatty acids on bronchial inflammation in asthma</article-title>
<source>World Allergy Organization Journal</source>
<year>2020</year>
<volume>13</volume>
<issue>8</issue>
<elocation-id>100204</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.waojou.2020.100204</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>[40]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dickson</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>van der Poll</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Schouten</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Falkowski</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Luth</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Sjoding</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Chanderraj</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Huffnagle</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Bos</surname>
<given-names>LDJ</given-names>
</name>
<etal/>
</person-group>
<article-title>Lung microbiota predict clinical outcomes in critically ill patients</article-title>
<source>American Journal of Respiratory and Critical Care Medicine</source>
<year>2020</year>
<volume>201</volume>
<issue>5</issue>
<fpage>555</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.201907-1487oc</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>[41]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marotz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Belda-Ferre</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cantrell</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Diner</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment</article-title>
<source>Microbiome</source>
<year>2021</year>
<volume>9</volume>
<issue>1</issue>
<pub-id pub-id-type="doi">10.1186/s40168-021-01083-0</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>[42]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Metage-nomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19</article-title>
<source>Signal Transduction and Targeted Therapy</source>
<year>2021</year>
<volume>6</volume>
<issue>1</issue>
<pub-id pub-id-type="doi">10.1038/s41392-021-00614-3</pub-id>
</element-citation>
</ref>
<ref id="R43">
<label>[43]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakajima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Leggett</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Coulter</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Millar</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Goldsmith</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>Population structure and characterization of viridans group streptococci (vgs) isolated from the upper respiratory tract of patients in the community</article-title>
<source>The Ulster medical journal</source>
<year>2013</year>
<volume>82</volume>
<issue>3</issue>
<fpage>164</fpage>
</element-citation>
</ref>
<ref id="R44">
<label>[44]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noguchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yatera</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kawanami</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Naito</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Akata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shimabukuro</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ishimoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yoshii</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mukae</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The clinical features of respiratory infections caused by the streptococcus anginosus group</article-title>
<source>BMC Pulmonary Medicine</source>
<year>2015</year>
<volume>15</volume>
<issue>1</issue>
<pub-id pub-id-type="doi">10.1186/s12890-015-0128-6</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>[45]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kemnic</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Raziq</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Gami</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Streptococcus Anginosus Lung Abscess With Coronavirus 2019 Pneumonia</article-title>
<source>Chest</source>
<year>2020</year>
<volume>158</volume>
<issue>4</issue>
<fpage>515</fpage>
<pub-id pub-id-type="doi">10.1016/j.chest.2020.08.491</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Fig. 1</label>
<caption>
<title>Study cohort overview.</title>
<p>A) The number of samples collected in different months and in different cities. The black line shows the number of newly identified SARS-CoV-2 infection cases in Russia. B) distribution of patients by age, sex, city of sampling, hospitalization status for all patients included in the study. C) The clinical characteristics of inpatients are shown: the percentage of lung damage, computer tomography severity score (CT), the need for additional oxygen supply as well as the presence of hypertension as a concomitant disease.</p>
</caption>
<graphic xlink:href="EMS135455-f001"/>
</fig>
<fig id="F2" position="float">
<label>Fig. 2</label>
<caption>
<title>Microbial community types analysis.</title>
<p>A) Heatmap visualization of taxonomic profiles on the genus level with inferred community type and city of sampling designated with color; Alicante city corresponds to external samples obtained in the study [10.3389/fmicb.2021.637430]. B) PCoA diagram based on unifrac distances between samples; color shows the city from which the sample was collected, the form - the type of community. C) Cluster analysis using DMM modeling infers six types of microbial communities based on the Laplace approximation.</p>
</caption>
<graphic xlink:href="EMS135455-f002"/>
</fig>
<fig id="F3" position="float">
<label>Fig. 3</label>
<caption>
<p>Factors associated with the type of microbial community of the upper respiratory tract. The negative logarithm of p-value is shown for the Kruskal-Wallis test for numerical variables (a) and in the chi-square test for categorical variables (b); the association between the individual variable and the type of community was estimated, the larger the value, the more significant the association. C) the importance of variables (mean decrease Gini index) in the random forest is shown. Month, city and hospital id concerns the sampling of the material; age, temperature, oxygen saturation, respiratory rate, heart rate, blood pressure (diastolic) and blood pressure (systolic), being conscious (is_concious) and being hospitalized (inpatient), the need for additional oxygen supply (additional O2) are the factors describing the patient’s condition; obesity, smoking, smoking before, diabetes, COPD (chronic obstructive pulmonary disease), IBD (inflammatory bowel disease), arthritis, tuberculosis, hypertension, coronary artery disease, chronic heart failure, asthma are concomitant diseases of the patient and his habits, lineage is the SARS-CoV-2 genome Pangolin classification.</p>
</caption>
<graphic xlink:href="EMS135455-f003"/>
</fig>
<fig id="F4" position="float">
<label>Fig. 4</label>
<caption>
<p>The association between the microbial community type and the severity of the disease. The distribution of the proportion of lungs affected (A) and the need for additional oxygen supply (B) by community types is shown. The alpha diversity (measured as Shannon index) of different community types (C). Section D shows the distribution by type of communities of patients from the study [<xref ref-type="bibr" rid="R23">23</xref>]; groups show the severity of the disease (group A: SARS-CoV-2 negative patients (n = 18); group B: mild COVID-19 symptoms but no later hospital admission (n = 19); group C: severe COVID-19 symptoms followed by hospital admission (n = 18); and group D: patients with severe COVID-19 symptoms which were eventually admitted into intensive care units (n = 19))</p>
</caption>
<graphic xlink:href="EMS135455-f004"/>
</fig>
<fig id="F5" position="float">
<label>Fig. 5</label>
<caption>
<p>The differentially abundant taxa testing associations. Bacteria on the genus (A) and ASV (B) levels that differ in abundance in inpatients with severe (CT ¿ 2) and mild (CT = 1) level of lung damage. The analysis was carried out using the DeSeq2 method. Bacteria which are more abundant in more severe patients are shown in bars pointing to the right, in lighter patients - to the left. Asterisks indicate the level of significance with the following thresholds: (*) = 0.1, (**) = 0.05, (***) = 0.01.</p>
</caption>
<graphic xlink:href="EMS135455-f005"/>
</fig>
</floats-group>
</article>
